CN100409865C - Compound medicine for treating hepatitis B - Google Patents
Compound medicine for treating hepatitis B Download PDFInfo
- Publication number
- CN100409865C CN100409865C CNB2006100858681A CN200610085868A CN100409865C CN 100409865 C CN100409865 C CN 100409865C CN B2006100858681 A CNB2006100858681 A CN B2006100858681A CN 200610085868 A CN200610085868 A CN 200610085868A CN 100409865 C CN100409865 C CN 100409865C
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- gram
- rhizoma
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 19
- 150000001875 compounds Chemical class 0.000 title abstract description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 8
- 241000222336 Ganoderma Species 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 15
- 241000190633 Cordyceps Species 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 241000255791 Bombyx Species 0.000 claims description 7
- 241000756943 Codonopsis Species 0.000 claims description 7
- 241001489978 Eupolyphaga Species 0.000 claims description 7
- 241000237903 Hirudo Species 0.000 claims description 7
- 239000010231 banlangen Substances 0.000 claims description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 7
- 210000002826 placenta Anatomy 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 208000006454 hepatitis Diseases 0.000 abstract description 5
- 206010008909 Chronic Hepatitis Diseases 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 2
- 208000000419 Chronic Hepatitis B Diseases 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000003908 liver function Effects 0.000 description 6
- 238000010791 quenching Methods 0.000 description 6
- 238000007689 inspection Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 3
- 208000019425 cirrhosis of liver Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000007449 liver function test Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- OBHRVMZSZIDDEK-UHFFFAOYSA-N urobilinogen Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(CC3C(=C(CC)C(=O)N3)C)N2)CCC(O)=O)N1 OBHRVMZSZIDDEK-UHFFFAOYSA-N 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 1
- 101710142246 External core antigen Proteins 0.000 description 1
- 241001149422 Ganoderma applanatum Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 206010019759 Hepatitis chronic persistent Diseases 0.000 description 1
- 206010056972 Hydrocholecystis Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000012550 audit Methods 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000003810 lymphokine-activated killer cell Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 108010001062 polysaccharide-K Proteins 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001179 pupillary effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Natural products CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 1
- 125000003639 thymyl group Chemical group C1(=CC(C)=CC=C1C(C)C)* 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses a compound Yiganqing Chinese medicine preparation with the functions of protecting liver, supplementing kidney, promoting blood circulation and removing blood stasis for mainly curing chronic hepatitis and hepatitis B. Said compound Yiganqing Chinese medicine preparation is made up by using 19 Chinese medicinal materials of astragalus root, gynostemma pentaphyllum, piloze asiabell root, poria, isatis root, white peony root, ganoderma and others through a certain preparation process.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of hepatitis B and preparation method thereof.
Background technology
All diseases have a common basic factor, are exactly the positive QI-insufficiency of human body, and modern medicine thinks that immunity reduces.Ancient medicine was also once done summary highly to this factor and pathogeny, and " interior warp " has cloud: " institute of heresy gathers, and its gas must be empty " this also is the basic characteristics of pathogenesis.Simultaneously " interior warp " proposed the basic concept of " healthy energy deposit in, heresy can not be done " again aspect prevent disease.
Although whether the power of human body falls ill and extraneous pathogen has relation, its key is human righteousness's power, and " all kinds of diseases and ailments are all taken advantage of a weak point and given birth to " also has been described.Hepatitis B is no exception.
Hepatitis B, the pathogenesis complexity is easy to repeatedly, also difficult the elimination.Its root is existing hepatic injury-weakened body resistance one side, have hepatitis B virus to hide-one side of the domination of pathogen again, and implement among the whole course of disease, again because of eliminating evil detoxifcation, damp eliminating, invigorate blood circulation and easily hinder healthy energy, set upright and easily love evil, so clinical treatment is rather thorny.
Summary of the invention
The objective of the invention is to: a kind of Chinese medicine composition for the treatment of hepatitis B and preparation method thereof is provided, and both eliminating evil affair turns round and look at again everywhere and protects healthy energy to the greatest extent, and eliminating pathogenic factor for supporting vital QI is also executed, and accomplishes the end in view.
Technical solution of the present invention is: said composition is made up of following drug matching: the Radix Astragali 500 grams, Herb Gynostemmae Pentaphylli 500 grams, Radix Codonopsis 300 grams, pig Poria 200 grams, Radix Isatidis 200 grams, the Radix Paeoniae Alba 200 grams, Ganoderma 150 grams, the Rhizoma Atractylodis Macrocephalae 150 grams, Rhizoma Osmundae 150 grams, Rhizoma Cimicifugae 150 grams, Radix Salviae Miltiorrhizae 150 grams, Radix Paeoniae Rubra 100 grams, Eupolyphaga Seu Steleophaga 100 grams, Hirudo 100 grams, Bombyx Batryticatus 100 grams, Rhizoma Paridis 100 grams, Placenta Hominis 100 grams, Cordyceps 50 grams, Radix Glycyrrhizae 50 grams.
The manufacture method of compositions of the present invention is as follows: 1. the Radix Astragali 500 grams, Herb Gynostemmae Pentaphylli 500 grams, Radix Codonopsis 300 grams, pig Poria 200 grams, Radix Isatidis 200 grams, the Radix Paeoniae Alba 200 grams, Ganoderma 150 grams, the Rhizoma Atractylodis Macrocephalae 150 grams, Rhizoma Osmundae 150 grams, Rhizoma Cimicifugae 150 grams, Radix Salviae Miltiorrhizae 150 grams, Radix Paeoniae Rubra 100 grams, Eupolyphaga Seu Steleophaga 100 grams, Hirudo 100 grams, Bombyx Batryticatus 100 grams, Rhizoma Paridis 100 grams, Placenta Hominis 100 grams, Cordyceps 50 grams, Radix Glycyrrhizae 50 grams dry fine grinding and transfer evenly; 2. add suitable decocting with Herba Verbenae 500 grams and get extract; 3. standby with this juice for water pill.
The instructions of taking of compositions of the present invention: 8 grams of at every turn taking medicine, 3 times on the one, early, middle and late half is after meal respectively obeyed 1 time.
The clear replenishing QI to invigorate the spleen of the present composition, liver protecting and kidney invigorating, blood circulation promoting and blood stasis dispelling, softening hard tissue.Cure mainly chronic persistent hepatitis and hepatitis B virus carriers, the early stage liver cirrhosis patient that the especially damp and hot stasis of blood is strongly fragrant.Regulate immunologic function, remove the intracellular toxin of blood regulating liver-QI, promote liver cell regeneration, improve clinical symptoms and sign, recover liver function, anti-treating the liver fiber and liver cirrhosis.
The present composition is selected Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Ganoderma Lucidum, pig Poria replenishing QI to invigorate the spleen dampness for use, meets the Zhong Jing intention of " seeing the disease of liver, in the ban tonifying the spleen "; The Radix Salviae Miltiorrhizae nourshing blood and promoting blood circulation; The thing that Eupolyphaga Seu Steleophaga, Hirudo, Bombyx Batryticatus are all agile, blood circulation promoting and blood stasis dispelling eliminating mass, red Radix Paeoniae Alba easing the affected liver to relieve pain; Radix Isatidis, Rhizoma Osmundae, Rhizoma Cimicifugae, Radix Glycyrrhizae heat-clearing and toxic substances removing promote liver cell regeneration; Herb Gynostemmae Pentaphylli, Cordyceps are sweet in flavor and warm in property, tonifying deficiency is arranged, the merit of benefit vital essence, return lung, spleen, liver, kidney four warps, Cordyceps contains crude protein, several amino acids, sugar, alcohols and trace element, can strengthen people's body's immunity, and can improve liver function, reduce glutamate pyruvate transaminase, suppress---the rising of globulin; The Radix Astragali has antiviral, and enhancing antibody forms, and prolongs the effect of cells in vitro time-to-live, improves the killing activity of LAK cell; The Rhizoma Paridis antiinflammatory can be prevented canceration; The Herba Verbenae cold nature, bitter in the mouth acid has the interior heat clearing away of dispelling, and the merit of crimson blood removing food stagnancy can be improved liver function, fries in shallow oil water pill with this, and its effect is better.
The applicant accepts 102 people for medical treatment with compositions of the present invention, cures 71 people, cures 25 people substantially, invalid 6 people, and total effective rate is 95%.
The specific embodiment
Chinese medicine composition of the present invention is made up of following drug matching: the Radix Astragali 500 grams, Herb Gynostemmae Pentaphylli 500 grams, Radix Codonopsis 300 grams, pig Poria 200 grams, Radix Isatidis 200 grams, the Radix Paeoniae Alba 200 grams, Ganoderma 150 grams, the Rhizoma Atractylodis Macrocephalae 150 grams, Rhizoma Osmundae 150 grams, Rhizoma Cimicifugae 150 grams, Radix Salviae Miltiorrhizae 150 grams, Radix Paeoniae Rubra 100 grams, Eupolyphaga Seu Steleophaga 100 grams, Hirudo 100 grams, Bombyx Batryticatus 100 grams, Rhizoma Paridis 100 grams, Placenta Hominis 100 grams, Cordyceps 50 grams, Radix Glycyrrhizae 50 grams.
The manufacture method of Chinese medicine composition of the present invention is as follows: 1. the Radix Astragali 500 grams, Herb Gynostemmae Pentaphylli 500 grams, Radix Codonopsis 300 grams, pig Poria 200 grams, Radix Isatidis 200 grams, the Radix Paeoniae Alba 200 grams, Ganoderma 150 grams, the Rhizoma Atractylodis Macrocephalae 150 grams, Rhizoma Osmundae 150 grams, Rhizoma Cimicifugae 150 grams, Radix Salviae Miltiorrhizae 150 grams, Radix Paeoniae Rubra 100 grams, Eupolyphaga Seu Steleophaga 100 grams, Hirudo 100 grams, Bombyx Batryticatus 100 grams, Rhizoma Paridis 100 grams, Placenta Hominis 100 grams, Cordyceps 50 grams, Radix Glycyrrhizae 50 grams dry fine grinding and transfer evenly; 2. add suitable decocting with Herba Verbenae 500 grams and get extract; 3. standby with this juice for water pill.
Chinese medicine composition instructions of taking of the present invention: 8 grams of at every turn taking medicine, 3 times on the one, early, middle and late half is after meal respectively obeyed 1 time.
The model case letter is lifted:
1, Zhang, the man, 39 years old, married, Huai level bridge people.The conscious malaise of patient, right costa sternales has a dull ache, and does not just mind.Because of busy, detect species of samples two and half in the Shanghai City Sixth People's Hospital, the specimen numbering: the 3. 0010607 HBSAg positive, anti----HBS feminine gender, HbeAg positive, anti----the weak positive of Hbe, anti-HBC (1: 100) positive to Shanghai.Seek medical advice behind the Hui Huai, with compound hepatitis B quench treatment, three months after the check of the People's Hospital, Huai, report NO:004209 inspection specimen two double, and HBSAg+----only, chronic HBSAg carrier is a little less than the infectiousness.Continuous clothes one material is consolidated, and turns out cloudy fully.Visit not morbidity again.
2, Dong, man, 13 years old, student, city, Huaihe River, Huai Huating people from group.Suffer from hepatitis and had a surplus in sick 2 years, it is all invalid to cure through Chinese and Western, checks that repeatedly hepatitis B antigen is all positive, low when high during glutamate pyruvate transaminase, dull pain in liver, and it is fragrant that Na Gu owes, and limbs fatigue is tested purpose HBS through the inspection report NO:018255 blood examination of the People's Hospital, Huai
2G BSAg 1: 128.Examine and see that body of the tongue is thin, the pulse condition stringy and thready pulse.Disease belongs to stagnation of liver-QI with deficiency of the spleen, pathogenesis stagnation of liver-QI, dysfunction of the spleen in transportation.With the compound hepatitis B quench treatment, obey material spirit rotational oscillation, all diseases disappear and heal.Liver function test is a normal value, and hepatitis B antigen is turned out cloudy.
3, Zhang, the man becomes, and is married, east, building, cities and towns, Huaihe River neighbourhood committee.Suffer from hepatitis B and had a surplus in 3 years, clothes MIEAOLING, compound recipe Ganoderma applanatum (Pers. Ex Wallr) Pat. sheet, liver-protecting tablet, krestin etc. do not take effect.Present liver function test result: SGPT200, TTTg, 2nTT14, HBSAg, the HbeAg positive.The right side of body of readme dull pain, distending pain discomfort sometimes, it is not smooth to breathe, dim complexion.It is greasy in thin to examine body of the tongue, stringy pulse.2cm under the palpation of liver rib, the inclined to one side I level of quality is hard.To sum up dialectically be: stagnation of QI due to depression of the liver.Recuperate under medical treatment for frying in shallow oil slowly with ball with compound hepatitis B quench, heal through obeying two material.Repeatedly section's inspection is normal value.As through the inspection report NO:0070864 of the People's Hospital, Huai Zhang Xiaolin, the man, 40 years old, specimen blood, the check purpose is the two double testing result HbSAg of hepatitis B system feminine gender, anti-HBS feminine gender, HBeAg feminine gender, anti-HBe feminine gender, anti-HBS feminine gender, HBe feminine gender, anti-HBe feminine gender, anti-HBC feminine gender.
4, Zhang, the man becomes, and 50 years old, lives drum tower Gang Er village, Zhengjiang City No. 75.The patient suffers from former icterohepatitis from April nineteen eighty-three, repeatedly repeatedly.Liver function is obviously unusual always over several years, is addicted to drink recently and falls ill with fatigue.Do not show though treat its effect, come the Huai treatment through Zhengjiang City institute.The ultrasonic liver and gall pancreas of the last No.2 People's Hospital, Huaian City's Type B spleen audit report singly prompts for: 1, liver cirrhosis, 2, moderate ascites, 3, cholecystitis, hydrocholecystis.Hepatic function test report: icteric index 62, total bilirubin 6.1, VDB ++, sulphuric acid turbidity 12, cotton-shaped by ten, glutamate pyruvate transaminase 200 units of thymol.Urine examination is: the red matter of gallbladder (++) urobilinogen (++) water gallbladder element ().Examine and meet the yellow yellowish urine pupillary membrane of yellow skin xanthochromia, thin enlarged abdomen of body such as drum, greasy floating yellow during body of the tongue is thin, weak digestive function of the spleen and stomach, limbs fatigue, pulse condition sink thin and moisten.To sum up distinguish disease being: the liver spleen is injured, and transport is not normal, and QI and blood is handed over resistance, stops in the aqueous vapor.The primary disease stagnation of liver-QI with deficiency of the spleen, damp and hot stifling, bile is excessive, and foul smell blocks wherein, and causing expanding is doctor trained in Western medicine cirrhotic ascites etc.Medical treatment is used compound hepatitis B quench treatment March instead and is healed after January.Repeatedly section's inspection is all healthy, does not send out hepatopathy.
5, Hu Hui, woman, 8 years old, student, town and country, Huai Zhao's canal people.Be diagnosed as chronic hepatitis through hospital, single transaminase cures with compound hepatitis B quench up to 840 units, visits so far not morbidity again, and liver function is repeatedly checked and is normal value.
6, Ding Erlan, the woman becomes, and is married, city east, Huai township grandson canal people.The chronic hepatitis companion 1-3-5 positive is turned out cloudy through taking the compound hepatitis B quench healing, does not visit morbidity again.
Claims (2)
1. Chinese medicine composition for the treatment of hepatitis B, it is characterized in that: said composition is made up of following Chinese medicine: the Radix Astragali, each 500 gram of Herb Gynostemmae Pentaphylli, Radix Codonopsis 300 grams, pig Poria, Radix Isatidis, each 200 gram of the Radix Paeoniae Alba, Ganoderma, the Rhizoma Atractylodis Macrocephalae, Rhizoma Osmundae, Rhizoma Cimicifugae, each 150 gram of Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Eupolyphaga Seu Steleophaga, Hirudo, Bombyx Batryticatus, Rhizoma Paridis, each 100 gram of Placenta Hominis, Cordyceps, each 50 gram of Radix Glycyrrhizae.
2. manufacture method for the treatment of the Chinese medicine composition of hepatitis B, it is characterized in that: 1. the Radix Astragali, Herb Gynostemmae Pentaphylli respectively 500 restrain, Radix Codonopsis 300 grams, pig Poria, Radix Isatidis, each 200 gram of the Radix Paeoniae Alba, Ganoderma, the Rhizoma Atractylodis Macrocephalae, Rhizoma Osmundae, Rhizoma Cimicifugae, each 150 gram of Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Eupolyphaga Seu Steleophaga, Hirudo, Bombyx Batryticatus, Rhizoma Paridis, each 100 gram of Placenta Hominis, Cordyceps, each 50 gram of Radix Glycyrrhizae dry fine grinding and transfer evenly; 2. add suitable decocting with Herba Verbenae 500 grams and get extract; 3. standby with this juice for water pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100858681A CN100409865C (en) | 2006-05-30 | 2006-05-30 | Compound medicine for treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100858681A CN100409865C (en) | 2006-05-30 | 2006-05-30 | Compound medicine for treating hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1891264A CN1891264A (en) | 2007-01-10 |
| CN100409865C true CN100409865C (en) | 2008-08-13 |
Family
ID=37596625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100858681A Expired - Fee Related CN100409865C (en) | 2006-05-30 | 2006-05-30 | Compound medicine for treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100409865C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101979070B (en) * | 2010-10-27 | 2011-12-28 | 苏桂华 | Chinese medicament for treating hepatitis B |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1385191A (en) * | 2002-06-04 | 2002-12-18 | 徐连豪 | Medicine for treating liver disease |
| CN1557396A (en) * | 2004-02-06 | 2004-12-29 | 梁兴家 | Chinese medicinal composition for treating hepatitis B |
-
2006
- 2006-05-30 CN CNB2006100858681A patent/CN100409865C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1385191A (en) * | 2002-06-04 | 2002-12-18 | 徐连豪 | Medicine for treating liver disease |
| CN1557396A (en) * | 2004-02-06 | 2004-12-29 | 梁兴家 | Chinese medicinal composition for treating hepatitis B |
Non-Patent Citations (2)
| Title |
|---|
| 乙肝汤治疗慢性迁延性乙型肝炎40例. 阚霖生.湖北中医杂志，第3期. 1989 |
| 乙肝汤治疗慢性迁延性乙型肝炎40例. 阚霖生.湖北中医杂志，第3期. 1989 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1891264A (en) | 2007-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100515482C (en) | Chinese traditional medicine for treating acute and chronic hepatitis | |
| CN102178800B (en) | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN103007191A (en) | Chinese medicinal composition for treating jaundice | |
| CN104353047A (en) | Traditional Chinese medicine for treating nephritis | |
| CN101433654A (en) | Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof | |
| CN101785810B (en) | Traditional Chinese medicine preparation for anaphylactoid purpura treatment | |
| CN102698207A (en) | Traditional Chinese medicine composition for treating hepatopathy and preparation method thereof | |
| CN108379521A (en) | Prostate cancer therapy liquid and preparation method thereof | |
| CN100409865C (en) | Compound medicine for treating hepatitis B | |
| CN102813815B (en) | Traditional Chinese medicine composition for treating chronic pyelitis | |
| CN1669580A (en) | Compound hepatitis B quench | |
| CN101461857A (en) | Medicament for treating severe hepatitis | |
| CN102274452A (en) | Traditional Chinese medicine for treating gall-stone | |
| CN101716311B (en) | Traditional Chinese medical pill for treating hepatitis B | |
| CN111228388A (en) | A pharmaceutical composition for treating hepatopathy, and its application method | |
| CN100418569C (en) | Chinese medicine for treating prostatitis | |
| CN101411859B (en) | Chinese medicine preparation for treating dysmenorrhea | |
| CN102335399B (en) | Chinese medicinal composition for treating liver cirrhosis in early stage | |
| CN114288380B (en) | A kind of traditional Chinese medicine composition for treating Crohn's disease and its application | |
| CN114470144B (en) | Prostate eliminating soup for inhibiting prostate fibrosis and preparation method thereof | |
| CN100408082C (en) | Chinese medicine for treating liver | |
| CN101987162B (en) | Traditional Chinese medical preparation for treating anaphylatic purpura nephritis nephrotic syndrome | |
| CN1231247C (en) | Medicine for curing diseases after setting contraceptive ring | |
| CN101623461B (en) | Hepatitis B detoxification soup | |
| CN101011525A (en) | Antihyperglycemic hepatoprotective agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080813 |